%0 Case Reports
%T Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression.
%A Kong BL
%A Stommel JM
%A Keck JM
%A Kilburn D
%A Streblow A
%A Egger J
%A Creason AL
%A Suciu CG
%A Guimaraes AR
%A Corless CL
%A Mills GB
%A Pejovic TB
%J JCO Precis Oncol
%V 8
%N 0
%D 2024 Jun
%M 38905574
%F 5.479
%R 10.1200/PO.23.00686
%X Case report of a HER2-expressed ovarian clear cell carcinoma with exceptional response to trastuzumab deruxtecan.